Literature DB >> 18501067

Stem cells in colon cancer.

Alexandra Pohl1, Georg Lurje, Michael Kahn, Heinz-Josef Lenz.   

Abstract

The concept that cancer might arise from a rare population of cells with stem cell-like properties was proposed 150 years ago. Increasing evidence during the past 2 decades suggests the existence of a small subgroup of cells in cancer that are responsible for tumor growth and proliferation. Stem cells have self-renewing properties; thus, they are appealing candidates for generating the malignant phenotype. Although the concept of stem cells in leukemia has received significant attention for more than the past decade, over the past several years, expression of several surface markers on cancer cells has led to identification of tumor-initiating cells in several solid tumors, including melanoma, brain, breast, prostate, liver, pancreatic, ovarian, and recently, colon cancer. This review will provide an update of the biologic basis of the stem cell model and possible targets for the treatment of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501067     DOI: 10.3816/CCC.2008.n.012

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  8 in total

1.  Colon cancer stem cells: a new target in the war against cancer.

Authors:  Heinz-Josef Lenz
Journal:  Gastrointest Cancer Res       Date:  2008-07

2.  Differential remodeling of extracellular matrices by breast cancer initiating cells.

Authors:  Anju M Raja; Shuoyu Xu; Shuangmu Zhuo; Dean C S Tai; Wanxin Sun; Peter T C So; Roy E Welsch; Chien-Shing Chen; Hanry Yu
Journal:  J Biophotonics       Date:  2015-01-19       Impact factor: 3.207

3.  Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications.

Authors:  Georg Lurje; Marc Schiesser; Andreas Claudius; Paul Magnus Schneider
Journal:  J Oncol       Date:  2009-11-05       Impact factor: 4.375

Review 4.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

5.  Enteric bacteria and cancer stem cells.

Authors:  Jun Sun
Journal:  Cancers (Basel)       Date:  2010       Impact factor: 6.639

6.  Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.

Authors:  D Bose; L J Zimmerman; M Pierobon; E Petricoin; F Tozzi; A Parikh; F Fan; N Dallas; L Xia; P Gaur; S Samuel; D C Liebler; L M Ellis
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

7.  Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy.

Authors:  A Pohl; A El-Khoueiry; D Yang; W Zhang; G Lurje; Y Ning; T Winder; S Hu-Lieskoven; S Iqbal; K D Danenberg; M Kahn; J-L Teo; J Shriki; J Stebbing; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2012-01-10       Impact factor: 3.550

8.  Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Darryl Shibata; Christina Curtis; Simon Tavaré
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.